SG Power Limited has announced a significant strategic shift aimed at strengthening its future growth prospects through diversification into the healthcare and pharmaceutical industries.
According to the Company’s Third Quarter Report for the period ended March 31, 2026, the Board of Directors has carefully reviewed the current business environment and approved the expansion of the Company’s principal line of business into healthcare-related sectors. This decision comes after evaluating market conditions and identifying emerging opportunities that align with long-term value creation.
Strategic Business Expansion
The Company plans to engage in the import, sale, purchase, rental, distribution, marketing, and supply of medical equipment, instruments, devices, and healthcare supplies. In addition, SG Power Limited intends to participate in the manufacturing, distribution, import, export, and sale of pharmaceutical products, including synthetic drugs and related healthcare preparations.
This strategic initiative reflects the Company’s commitment to establishing a sustainable business model while addressing the growing demand for quality healthcare products and services.
Building a Strong Healthcare Presence
SG Power Limited aims to create a comprehensive healthcare ecosystem by developing partnerships with hospitals, clinics, healthcare professionals, and industry stakeholders. The Company will focus on delivering reliable medical equipment and pharmaceutical products while maintaining high standards of quality, compliance, and customer service.
Management believes that the healthcare sector presents substantial opportunities for long-term growth, supported by increasing healthcare awareness, technological advancements, and rising demand for medical solutions.
Commitment to Stakeholders
The Board remains dedicated to protecting shareholder interests and enhancing corporate value through strategic diversification. By entering healthcare and pharmaceutical markets, SG Power Limited seeks to reduce business concentration risks and establish multiple revenue streams that can support sustainable growth in the years ahead.
The Company appreciates the continued support of its shareholders, regulatory authorities, business partners, and stakeholders as it embarks on this new chapter of corporate development.
Looking Ahead
As SG Power Limited progresses with its transformation strategy, management remains focused on identifying new opportunities, strengthening operational capabilities, and delivering value to shareholders. The Company’s expansion into healthcare marks an important milestone in its evolution and positions it to capitalize on opportunities within one of the world’s fastest-growing industries.
SG Power Limited looks forward to sharing further updates as implementation of its healthcare and pharmaceutical initiatives advances.
